Pharma shares under pressure; Aurobindo, Wockhardt, Hikal, Natco down 6%

Natco Pharma said that a US District Court has issued a decision in favour of Pharmacyclics (a subsidiary of AbbVie), the brand owner of Imbruvica in a PIV litigation involving the product..

Shares of pharmaceutical companies came under pressure in Friday's session, falling by up to 6 per cent on the BSE. 

Wockhardt, Aurobindo Pharma, Hikal and Natco Pharma were down 6 per cent each in intra-day trade today. Granules India, Strides Pharma Science, Unichem Laboratories, Morpen Laboratories, Lupin, Dr Lal PathLabs and Glenmark Pharmaceuticals were down between 3 per cent and 5 per cent on the BSE.

At 02:31 pm, the S&P BSE Healthcare index shed 1.8 per cent, as compared to a 0.28 per cent decline in the S&P BSE Sensex.

Among individual stocks, Natco Pharma tanked 6 per cent to Rs 911